Long-term auction rate security investments 15,825 -
Goodwill and other, net 85,977 86,537
Total assets $603,544 $596,695
Liabilities and stockholders' equity:
Current liabilities $37,386 $46,141
Non-current liabilities 10,999 18,827
Stockholders' equity 555,159 531,727
Total liabilities and stockholders' equity $603,544 $596,695
Unaudited Condensed Consolidated Cash Flow Data
Three months ended January 31,
2008 2007
Operating activities:
Net income $8,669 $2,750
Non-cash items 12,015 8,641
Changes in operating assets and liabilities, net (5,568) (16,323)
Net cash provided by (used in) operating activities 15,116 (4,932)
Investing activities:
(Purchase) sale of investments and marketable
securities, net (11,150) 6,850
Expenditures for property, plant and equipment (1,866) (1,628)
Repurchase of sale-leaseback equipment - (3,910)
Capitalization of intangible assets (799) (2,710)
Net cash used in investing activities (13,815) (1,398)
Financing activities:
Repayments of notes payable and other
long-term obligations, net (252) (252)
Borrowings under revolving credit facility, net - 5,000
Proceeds from stock option exercises and
other, net
'/>"/>
| SOURCE Martek Biosciences Corporation Copyright©2008 PR Newswire. All rights reserved |